WHO ICTRP trial

Efficacy of Majoon-e-Sarakhs in Primary Hypothyroidism

CTRI/2018/02/011962 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2018/02/011962
Public title Efficacy of Majoon-e-Sarakhs in Primary Hypothyroidism
Scientific title Evaluation of the add on effect of Majoon-e-Sarakhs with levothyroxine in Primary Hypothyroidism
Primary sponsor National Institute of Unani Medicine
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India
Conditions Health Condition 1: null- Diagnosed cases of Primary Hypothyroidism
Interventions Intervention1: Majoon-e-Sarakhs and levothyroxine: Oral Route: Dose: 10 gm twice a day Oral Route: 1.6 μg/kg Body weight /day Control Intervention1: levothyroxine: Oral Route: 1.6 μg/kg Body Weight /day
Registration date Feb 19, 2018
Target size 100
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations